CANSA: Hollard DareDevil Run 2018

#DaredevilRun2018

Your Options for Participation are Limited to ONE

A 5km Run with a Difference that Makes a Difference

The Hollard DareDevil Run has grown from one brave soul daring to jog through peak hour traffic in a Speedo, to a massive countrywide phenomenon with a noble cause.

The only way to beat cancer is to raise awareness through initiatives like the Hollard DareDevil Run. Because early detection saves lives.

So check your jewels, pull on that purple DareDevil Speedo and let’s run cancer outta town. After all “It’s the one time in the year where you can run almost naked and not get arrested.” Sounds like a fair trade-off in the fight against cancer. #DaredevilRun2018 literally saves lives.

#WozaBozza

Says Thulani Sibisi, 2 Oceans Marathon winner and prostate cancer survivor: “I knew the word ‘cancer’. But I didn’t know what it was about. Now, I know’ – see why Thulani believes initiatives like DareDevil are vital in raising awareness about male cancers:

VIDEO INTERVIEW Thulani Sibisi:

Thulani Sibisi

So sign up at www.daredevilrun.com, join us on Friday, 16 March in #Johannesburg, #CapeTown, #Durban, #Bloemfontein and#Mbombela – let’s run cancer out of town! #WozaBozza

#WozaBozza

CANSA MANVan

Make some noise for the CANSA MANVan, sponsored by Hollard! This is your roving mobile clinic, bozza – an unstoppable force that’s driven to fight male cancers by providing PSA tests to men age 40+

The CANSA MANVan, sponsored by Hollard, is coming to your area soon. Be on the lookout for our MANVan and get free health checks, cancer screening and awareness materials to help you lower your cancer risk. The MANVan is shared between all regions that participate in the #DaredevilRun2018.

CANSA ManVan

Screening Offered:

  • Blood pressure
  • Blood sugar level
  • BMI and a body composition analysis
  • Skin scanner analysis – FotoFinder skin screening ( on request)
  • ** Prostate Specific Antigen (PSA) fingerpick tests for males older then 40 – to help detect prostate abnormalities
  • Health awareness sessions offering advice on improving health and providing information on the early signs and symptoms of various cancers

** PSA is a protein produced by both cancerous (malignant) and non-cancerous (benign) prostate tissue. High PSA levels may indicate inflammation of the prostate or even cancer. A blood test or finger prick test can establish if PSA levels are raised.

Your options for participation are limited to ONE:

Run cancer out of town

Who will you run for?

#DaredevilDedication – Hollard calls on all Daredevils to dedicate their run to someone they know or love who has been affected by cancer. Runners can share their dedications on signboards, or even write them on themselves, seeing as there will be so much skin on show!

Who will you run for?

Show us the money for NCDs – draft health budget

Numbers don’t lie, especially if you take a look at the place of NCDs in the draft health budget. The words about NCDs imply commitment to solving a huge health problem.   That is superficial though when it comes to NCDs. There a heaps of great sounding words (policies and plans) but a clear lack of money. Especially for screening and treatment. Words, even printed ones, are cheap. Little has changed:

Whilst the Minister in the preamble of the Annual Performance Plan highlights importance of tackling non-communicable diseases (NCDs) there doesn’t appear to be any dramatic shift in budget allocation over the Medium Term. Can the department provide reasons for this?
Issues for consideration Parliament Research Unit. Vote15: Health Budget 2014/15 p.6

Health is allocated less than 5% of the proposed national budget (Figure 1). Defense get more yet SA loses more people to NCDs each day than in armed conflicts. Where are our national priorities?

2015budgetpie

Figure 1:

Looking at the details of the health budget

health budges

The smallest by far is Programme 4 for Primary Health Care (PHC) services (R 225 -million)
Most People Living With NCDs  get care at primary health care (PHC) clinics and this appears to be the reasoning why NCDs are placed within Prog 4 . People living with HIV/AIDS

Our information comes from the draft Annual Performance Plan (APP) and its accompanying budget.  – see pages 61-63. Click here to download the draft APP 2015/2016-2017/8

Fast facts stacking up Programme 4 vs other NDoH Programmes 2015/16

Smallest programme
budget by far
See Figure 2
1st place people costs Programme 4 cost of PEOPLE EMPLOYED R186.2 million = ↓ money available for implementation
2nd largest # people
employed
458 by only 10 people short of no 1 placed Programme 1 (p. 27)
Only programme to increase personnel costs Leaving less to spend on implementing programmes/ plans

3 NCDs issues related to HIV/AIDS and Maternal Child health appear in Prog 3 budget (cancer cervix, breast cancer policy, immunizations.) Cancer of the prostate does not warrant a mention in the APP.
The key to the APP is words not allocation of funds. Again NCDs screening and treatment is left high and dry.

Fast facts about NCDs Prog 4 budget

Where is the money for implementation of the NCDs plan in this budget?

89.37%  for people working on projects – personnel, contractors and consultants
0           for screening of target of 8 million people for high BP and blood glucose OR
NCDs Commission/ Health Commission
(more next week on this)
1.3 %       NGOs or non-profits  (< R 3-million) > 50% goes to 2 of 6 NGOs
National Council Against Smoking & SA National Council for the Blind.

prog 4 sub prog allocation

NCDs prevention and treatment cross cuts all Programmes especially at the PHC level. So we need to look at inside other programmes. However, without exception there is no separate financial allocation for stated NCDs targets like for example breast cancer policy development and cancer of the cervix screening in Programme 3 (HIV/AIDS & TB.)  Innovations like “ideal clinics” which are supposed to include NCDs take place without consulting NCDs civil society organisations.

Examples from Programme 2: NHI

  • Drug procurement and stock out management (all drugs including ARVs)
  • National Cancer Registry (words no money)

Programme 3: HIV/AIDS & TB

  • Cervical cancer screening
  • Breast cancer policy (more words no money)
  • Vaccinations against hepatitis & human papilloma virus
  • Obesity policy (more words no money)

Watchdogs must bark. An NCDs advocacy series. This is the first in a series on NCDs in policy documents.

Which 3 provinces met cervical cancer screening targets in 2014?

Cervical cancer screening coverage by province

Cervical cancer screening coverage by province

Cancer of the cervix (CaCx) is the only NCDs indicator monitored in the District Health Barometer 2013-2014 due its historical focus on Millennium Development Goals.

  • Cervical cancer (CaCx) is the 2nd most frequent cancer among SA women
  • Most frequent cancer among women between 15-44 years
  • 43 million women aged ≥15 years are at risk
  • 7,735 women are diagnosed with CaCx every year
  • 4, 248 die from CaCx.
  • 21% of women in the general population are estimated to have cervical HPV infection at a given time
  • Over 60% of invasive CaCx are attributed to HPVs 16 or 18.m
  • HPV vaccination of girls before sexual activity is the best primary prevent

It is the nearly 20 million women who are at risk that need the CaCx screening and the ones below are only of women 30 and older. Only screening tests are considered… that is to find those who need further investigation.

  • 1st place: KZN is the best performing province for the second year running.
  • 2nd place:  North West improved increased its performance by 13.1%
  • 3rd place: Western Cape

Webinar Breast cancer screening and early detection

Pan American Health Organization / WHO ow.ly/I0xVz

16:30         Registration online RSVP (for attendance in person or virtual) by registering at: http://bit.ly/1DPS3Ae

17:00          OPENING REMARKS

Dr. Anselm Hennis, Director of the Department on Noncommunicable Diseases and Mental Health

17:10          EVIDENCE REVIEW: Scientific evidence on breast cancer screening

Dr. Ben Anderson, Global Breast Cancer Alliance and Fred Hutchinson Cancer Research Center

17:30          CLOSING THE BREAST CANCER DIVIDE: The case for investing in breast cancer screening

Dr. Felicia Knaul, Harvard Global Equity Initiative

17:50          PROGRAM EXPERIENCE: How The Bahamas has addressed breast cancer screening

Dr. Larry Carroll, Bahamas Breast Cancer Initiative

18:10          COMMUNITY MOBILIZATION: A civil society perspective on raising awareness of breast cancer

Dr. Maira Caleffi, FEMAMA

18:30          DISCUSSION

18:45          CLOSING REMARKS